Skip to main content
. 2021 Aug 16;22(16):8802. doi: 10.3390/ijms22168802

Figure 2.

Figure 2

TAAR5 expression in the dorsolateral prefrontal cortex of healthy humans and patients with different neuropsychological or psychiatric conditions. (a) Downregulation of TAAR5 expression in Down syndrome patients (GSE5390, adult Down syndrome, n = 9, healthy controls, n = 6); (b) dysregulation of TAAR5 expression in patients with psychiatric disorders (GSE92538, bipolar disorder, n = 12, major depressive disorder, n = 29, schizophrenic, n = 31, control group, n = 55). BpD—bipolar disorder, MDD—major depressive disorder, Shz—schizophrenia.